DMD and Duchenne muscular dystrophy: We show that this strategy multiplies the therapeutic effect both in vitro and in newly regenerated muscle fibres in the in vivo DMD model, leading to abundant dystrophin production, in a range that is considered therapeutically effective (Kinali et al, 2008).